Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study.
CONCLUSIONS: Real-world evidence indicates that few high-risk patients initiate therapy with high-intensity statins. More than 50% of patients underwent a rechallenge or switching. Despite high CVD risk profile, approximately 20% of patients permanently discontinued any LLT. Key limitations: Pharmacy claims do not provide information on whether patients who had a pharmacy fill actually took the medication as prescribed. It is unknown whether rechallenge was a simple delay in filling a prescription or an actual rechallenge of their index therapy. Reasons for treatment discontinuations or modifications were unavailable in claims data.
PMID: 28276256 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Cholesterol | Coronary Angioplasty | Coronary Artery Bypass Graft | Databases & Libraries | Heart | Heart Attack | Insurance | Ischemic Stroke | Percutaneous Coronary Intervention | Research | Statin Therapy | Stroke | Study | Vytorin | Zetia